Holen Sie sich die Stockscreener-App
33.43
1.80%
-0.45
Schlusskurs vom Vortag:
$33.88
Offen:
$33.49
24-Stunden-Volumen:
47,932
Relative Volume:
0.06
Marktkapitalisierung:
$1.53B
Einnahmen:
$1.23B
Nettoeinkommen (Verlust:
$20.43M
KGV:
75.79
EPS:
0.4411
Netto-Cashflow:
$95.39M
1W Leistung:
-4.15%
1M Leistung:
-9.62%
6M Leistung:
-16.47%
1J Leistung:
+1.53%
1-Tages-Spanne:
$32.83
$33.60
1-Wochen-Bereich:
$32.83
$35.38
52-Wochen-Spanne:
$29.06
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Firmenname
Omnicell Inc
Sektor
Branche
Telefon
(877) 415-9990
Adresse
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, BTSG, TEM, TXG, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
33.46 | 1.55B | 1.23B | 20.43M | 95.39M | 0.4411 |
VEEV
Veeva Systems Inc
|
263.37 | 42.88B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
61.63 | 12.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
62.20 | 11.67B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
66.36 | 8.55B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
94.11 | 7.72B | 1.34B | 230.70M | 440.96M | 2.6695 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2026-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-05-14 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-11-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Bestätigt | Wells Fargo | Underweight |
| 2023-08-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Eingeleitet | BofA Securities | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-12-06 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-09 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-24 | Eingeleitet | BTIG Research | Buy |
| 2021-02-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-12-03 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-02-07 | Bestätigt | Dougherty & Company | Buy |
| 2019-11-21 | Bestätigt | Dougherty & Company | Buy |
| 2019-07-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-03-07 | Bestätigt | Dougherty & Company | Buy |
| 2018-06-29 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-09-05 | Bestätigt | The Benchmark Company | Buy |
| 2017-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2017-04-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Eingeleitet | Dougherty & Company | Buy |
| 2016-12-06 | Bestätigt | The Benchmark Company | Buy |
| 2016-07-07 | Bestätigt | FBR Capital | Outperform |
| 2016-03-21 | Bestätigt | Topeka Capital Markets | Buy |
| 2016-01-07 | Eingeleitet | The Benchmark Company | Buy |
| 2015-11-16 | Bestätigt | Topeka Capital Markets | Buy |
| 2015-10-30 | Bestätigt | FBR Capital | Outperform |
| 2015-09-28 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-07-31 | Bestätigt | Topeka Capital Markets | Buy |
Alle ansehen
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
Does Embedding TraceLink’s DSCSA Tools Into Omnicell Workflows Reframe Its Cloud and Recurring Revenue Story (OMCL)? - simplywall.st
Tracelink, Inc. and Omnicell, Inc. Integrate Dscsa Compliance Solution into Hospital Pharmacy Operations - marketscreener.com
Craig-Hallum Maintains Omnicell(OMCL.US) With Buy Rating - Moomoo
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations - PR Newswire
Precision Trading with Omnicell Inc. (OMCL) Risk Zones - Stock Traders Daily
Omnicell Inc (OMCL) Stock Up 6.3% and Still Undervalued -- GF Sc - GuruFocus
Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference - Yahoo Finance
Omnicell Inc. ($0.001 par value) (OMCL) Peer Comparison – Compare with Others - valueresearchonline.com
Omnicell Stock Price Forecast. Should You Buy OMCL? - StockInvest.us
Omnicell Inc. ($0.001 par value) (OMCL) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Omnicell: Offers Good Value, But Uncertainty Remains (NASDAQ:OMCL) - Seeking Alpha
KeyBanc reiterates Omnicell stock rating on large pipeline growth By Investing.com - Investing.com Canada
KeyBanc reiterates Omnicell stock rating on large pipeline growth - Investing.com
Trillium Asset Management LLC Buys New Position in Omnicell, Inc. $OMCL - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Omnicell President Sells 6,753 Shares - The Motley Fool
Omnicell Market Sentiment - Benzinga España
Bank of America Corp DE Has $19.39 Million Position in Omnicell, Inc. $OMCL - MarketBeat
Omnicell (OMCL) Quarterly Figures: The Bottom-Line Figure Beats Its Comparison; Stock Move: The Share Price Adds 1.28% in the Current UpdateFinancial Data - vinanet.vn
Zacks Research Has Bearish Estimate for Omnicell Q3 Earnings - MarketBeat
Rice Hall James & Associates LLC Invests $2.15 Million in Omnicell, Inc. $OMCL - MarketBeat
Omnicell VP and Chief Accounting Officer Submits Form 4 Detailing RSU Tax Withholding and ESPP Acquisition - Kalkine Media
Omnicell (OMCL) legal chief has 4,025 shares withheld for taxes - Stock Titan
Omnicell (NASDAQ: OMCL) exec holds 22,265.8924 shares after tax move - Stock Titan
Omnicell (NASDAQ: OMCL) CEO withholds stock to cover RSU taxes - Stock Titan
Research Analysts Set Expectations for Omnicell Q1 Earnings - MarketBeat
Omnicell (NASDAQ: OMCL) insider plans sale of 3,083 shares - Stock Titan
Omnicell, Inc. $OMCL Shares Acquired by Empowered Funds LLC - MarketBeat
Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins - TradingView
Q2 2026 Omnicell Inc Earnings Call Transcript - GuruFocus
Omnicell, Inc. (OMCL) Stock Forecasts - finance.yahoo.com
OMCL Falls 20.1% in a Month as Booking and Margin Risks Build - TradingView
Quantinno Capital Management LP Has $1.92 Million Position in Omnicell, Inc. $OMCL - MarketBeat
(OMCL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Omnicell, Inc. (OMCL) Stock Analysis: Strong Analyst Consensus with Over 55% Upside Potential - DirectorsTalk Interviews
Millennium reports 3.8% Omnicell (OMCL) stake in amended 13G filing - Stock Titan
Does Omnicell’s Profit Rebound And Higher 2026 Outlook Change The Bull Case For OMCL? - simplywall.st
First Trust Advisors LP Has $2.85 Million Stake in Omnicell, Inc. $OMCL - marketbeat.com
Royal Bank of Canada Sells 78,803 Shares of Omnicell, Inc. $OMCL - MarketBeat
Omnicell Inc (OMCL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OMNICELL, INC. 2026: Revenue $312.21M, EPS $0.52— 10-Q Summary - TradingView
Omnicell, Inc. (NASDAQ: OMCL) returns to profit with Q2 2026 growth - Stock Titan
Tranche Update on Omnicell, Inc.'s Equity Buyback Plan announced on May 22, 2025. - marketscreener.com
Omnicell, Inc. (OMCL) - DirectorsTalk Interviews
Here's Why Omnicell (OMCL) is a Strong Value Stock - Eastern Progress
Omnicell (OMCL) Is Down 12.5% After Raising 2026 Revenue Outlook And Returning To Profitability - Yahoo! Finance Canada
Weekly Recap: Omnicell, Inc. Q3/2026 revenue and analyst price target - TradingView
Piper Sandler Maintains Omnicell(OMCL.US) With Buy Rating, Cuts Target Price to $45 - Moomoo
Omnicell (OMCL) Stock May Be 42% Below Fair Value On Weak Guidance - Yahoo Finance
OMNICELL INC : PIPER SANDLER CUTS TARGET PRICE TO $45 FROM $55 - Bitget
Arrowstreet Capital Limited Partnership Has $9.32 Million Stake in Omnicell, Inc. $OMCL - MarketBeat
Finanzdaten der Omnicell Inc-Aktie (OMCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):